« Back
Reference Standards for the Validation of Myeloid Sequencing Assays
Reference Standards for the Validation of Myeloid Sequencing Assays
Submitted on 24 Oct 2018

M. Wang, H. Child, J. Stombaugh, M. Jakubowski, C. Peck, K. Cook, Y. Cheng, Z. Tu, J. Wickenden
Horizon Discovery Group
This poster was presented at American Society of Human Genetics Annual Meeting 2018
Poster Views: 151
View poster »
Poster Abstract
With the advent of more robust sequencing capabilities, pathogenic mutations have now been identified in genes from 5 main groups: signalling pathway proteins (e.g. CBL), transcription factors (e.g. RUNX1), epigenetic regulators (e.g. ASXL1), tumor suppressors (e.g. TP53) and components of the spliceosome (e.g. SF3B1). A recent influx of new myeloid gene panels for sequencing of these genes requires rigorous validation to ensure sufficient clinical accuracy, as errors can often occur in library prep, sequencing, analysis and interpretation of results. In order to support this effort, Horizon has developed a novel cell-line derived reference standard containing 22 variants across 19 genes involved in all of the main pathway groups, including CBL, RUNX1, ASXL1, TP53, SF3B1, JAK2, FLT3, ABL, KRAS and DNMT3A.Report abuse »
Creative Commons

Related Posters

Strategies for High-Titer Protein Expression Using the ExpiCHO and Expi293 Transient Expression Systems
Chao Yan Liu, Jian Liu, Wanhua Yan, Kyle Williston, Katy Irvin, Henry Chou, Jonathan Zmuda

A Chemically-Defined Baculovirus-Based Expression System for Enhanced Protein Production in Sf9 Cells
Maya Yovcheva, Sara Barnes, Kenneth Thompson, Melissa Cross, Katy Irvin, Mintu Desai, Natasha Lucki, Henry Chiou, Jonathan Zmuda

Development of an in vitro Model System for Newcastle Disease Virus Persistence in Bladder Cancer Cells
Ahmad U1,, Chan SC2, Chau DM1, Chia SL5, Abdullah S1,3, Yusoff K5 & Veerakumarasivam A1,4*

The EurOPDX EDIReX project: towards a European Research Infrastructure on patient-derived cancer models
E. Vinolo 1, J.P. Morris 1, D.G. Alférez 2, J. Arribas 3,4,5, C. Bernadó 3,4,5, A. Bertotti 6, A. Bruna 7, A.T. Byrne 8, C. Caldas 7, R.B. Clarke 2, N. Conte 9, R. Corsi 10, S. Corso 6, M. Crespo 3, A. Dahmani 11, V. Dangles-Marie 11, D. Decaudin 11, Z. Dudová 12, A. Fiori 6, S. Giordano 6, M. Hauptsmann 13, M. Hidalgo 14, C. Isella 6, S. de Jong 15, J. Jonkers 13, A. Křenek 12, O. Krijgsman 13, D. Kouřil 12, J.C. Lacal 14, L. Lanfrancone 16, E. Leucci 17, G.M. Mælandsmo 18, E. Marangoni 11, J. Mason 9, M.Th. Mayrhofer 19, A. Mazzocca 6, T.S. Meehan 9, E. Montaudon 11, F. Nem

Comparison of cfDNA Reference Material Prepared using Enzymatic Fragmentation or Sonication for the Validation of Liquid Bi
Hannah Child, Aldo Mele, Katarzyna Wilczynska, Julie Wickenden